Guo‐Bo Li

3.2k total citations
116 papers, 2.4k citations indexed

About

Guo‐Bo Li is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Guo‐Bo Li has authored 116 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 23 papers in Organic Chemistry and 17 papers in Epidemiology. Recurrent topics in Guo‐Bo Li's work include Antibiotic Resistance in Bacteria (17 papers), Computational Drug Discovery Methods (16 papers) and Pneumocystis jirovecii pneumonia detection and treatment (11 papers). Guo‐Bo Li is often cited by papers focused on Antibiotic Resistance in Bacteria (17 papers), Computational Drug Discovery Methods (16 papers) and Pneumocystis jirovecii pneumonia detection and treatment (11 papers). Guo‐Bo Li collaborates with scholars based in China, United Kingdom and United States. Guo‐Bo Li's co-authors include Lingling Yang, Shengyong Yang, Linli Li, Yu‐Hang Yan, Qing-Qing Dai, Yong Wu, Junlin Yu, Wenjing Wang, Zhujun Yu and Gen Li and has published in prestigious journals such as Nucleic Acids Research, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Guo‐Bo Li

111 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guo‐Bo Li China 28 1.1k 639 377 332 330 116 2.4k
Lorraine M. Deck United States 25 1.6k 1.5× 503 0.8× 172 0.5× 123 0.4× 306 0.9× 44 3.2k
Lucy A. Hunsaker United States 31 1.3k 1.2× 397 0.6× 214 0.6× 141 0.4× 265 0.8× 51 3.3k
Vincent Kam Wai Wong Macao 39 2.5k 2.3× 433 0.7× 781 2.1× 214 0.6× 72 0.2× 183 4.5k
Rongsheng Tong China 32 1.8k 1.7× 298 0.5× 216 0.6× 172 0.5× 104 0.3× 116 4.1k
Alena Líšková Slovakia 34 1.9k 1.8× 197 0.3× 212 0.6× 153 0.5× 156 0.5× 52 3.8k
Dharmendra Kumar Yadav India 33 1.5k 1.4× 760 1.2× 96 0.3× 574 1.7× 121 0.4× 196 3.7k
Rosanna Filosa Italy 30 796 0.7× 732 1.1× 126 0.3× 82 0.2× 91 0.3× 83 2.4k
Viney Lather India 26 1.1k 1.0× 294 0.5× 65 0.2× 214 0.6× 130 0.4× 99 2.7k
Maija Lahtela‐Kakkonen Finland 30 1.1k 1.0× 424 0.7× 404 1.1× 318 1.0× 33 0.1× 76 2.7k
Chenglong Li United States 48 3.6k 3.3× 673 1.1× 254 0.7× 333 1.0× 491 1.5× 173 6.1k

Countries citing papers authored by Guo‐Bo Li

Since Specialization
Citations

This map shows the geographic impact of Guo‐Bo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐Bo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐Bo Li more than expected).

Fields of papers citing papers by Guo‐Bo Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guo‐Bo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐Bo Li. The network helps show where Guo‐Bo Li may publish in the future.

Co-authorship network of co-authors of Guo‐Bo Li

This figure shows the co-authorship network connecting the top 25 collaborators of Guo‐Bo Li. A scholar is included among the top collaborators of Guo‐Bo Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo‐Bo Li. Guo‐Bo Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Li, Mingyu Han, Hailin Tang, et al.. (2025). Combination of Sodium Butyrate and Immunotherapy in Glioma: regulation of immunologically hot and cold tumors via gut microbiota and metabolites. Frontiers in Immunology. 16. 1532528–1532528. 7 indexed citations
2.
Hou, Xiaowen, Xiaodong Zeng, Yukun Hu, et al.. (2025). Co-delivery of SN38 and SR717 activates cGAS–STING for near-infrared II image-guided chemoimmunotherapy. Journal of Controlled Release. 386. 114129–114129.
3.
Xia, Xue, Xiaorong Wang, Wenqin Yang, et al.. (2025). Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer's disease. Acta Pharmaceutica Sinica B. 15(2). 1098–1111. 16 indexed citations
4.
Yu, Junlin, et al.. (2025). Pharmacophore-oriented 3D molecular generation toward efficient feature-customized drug discovery. Nature Computational Science. 5(10). 898–914. 2 indexed citations
5.
Yu, Junlin, et al.. (2025). Knowledge-guided diffusion model for 3D ligand-pharmacophore mapping. Nature Communications. 16(1). 2269–2269. 3 indexed citations
6.
Lai, Ruizhi, Li Hai, Ruifang Nie, et al.. (2024). Discovery, synthesis and biological evaluation of novel isoquinoline derivatives as potent indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase dual inhibitors. European Journal of Medicinal Chemistry. 279. 116852–116852. 3 indexed citations
7.
8.
Wang, Wenjing, et al.. (2024). Macrocyclic peptides: up-and-coming weapons to combat antimicrobial resistance. Signal Transduction and Targeted Therapy. 9(1). 81–81. 7 indexed citations
9.
Liu, Zemin, Linxia Liu, Yu‐Hang Yan, et al.. (2023). New ε-N-thioglutaryl-lysine derivatives as SIRT5 inhibitors: Chemical synthesis, kinetic and crystallographic studies. Bioorganic Chemistry. 135. 106487–106487. 3 indexed citations
10.
Feng, Yu, Yongqiang Yang, Siyao Wang, et al.. (2023). Characterization of a novel carbapenem-hydrolysing β-lactamase OXA-1041 in Escherichia coli. Journal of Antimicrobial Chemotherapy. 78(5). 1288–1294. 4 indexed citations
11.
12.
Yang, Yongqiang, Yu‐Hang Yan, Christopher J. Schofield, et al.. (2023). Metallo-β-lactamase-mediated antimicrobial resistance and progress in inhibitor discovery. Trends in Microbiology. 31(7). 735–748. 39 indexed citations
13.
14.
Li, Guo‐Bo, Xingyan Xu, Le Yang, et al.. (2023). Exploring the association between circRNA expression and pediatric obesity based on a case–control study and related bioinformatics analysis. BMC Pediatrics. 23(1). 561–561. 3 indexed citations
15.
Xu, Jiale, et al.. (2022). Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED–H3K27me3 Inhibitors for the Treatment of Lymphoma. Journal of Medicinal Chemistry. 66(1). 1063–1081. 13 indexed citations
16.
Shen, Zihao, et al.. (2021). ProfKin: A comprehensive web server for structure-based kinase profiling. European Journal of Medicinal Chemistry. 225. 113772–113772. 12 indexed citations
17.
18.
Yan, Yu‐Hang, Zhaofeng Li, Junlin Yu, et al.. (2021). Discovery of 3-aryl substituted benzoxaboroles as broad-spectrum inhibitors of serine- and metallo-β-lactamases. Bioorganic & Medicinal Chemistry Letters. 41. 127956–127956. 19 indexed citations
19.
Yuan, Shuo, Bo Wang, Qing-Qing Dai, et al.. (2021). Discovery of New 4-Indolyl Quinazoline Derivatives as Highly Potent and Orally Bioavailable P-Glycoprotein Inhibitors. Journal of Medicinal Chemistry. 64(19). 14895–14911. 41 indexed citations
20.
Liu, Sha, Li Jing, Zhujun Yu, et al.. (2018). ((S)-3-Mercapto-2-methylpropanamido)acetic acid derivatives as metallo-β-lactamase inhibitors: Synthesis, kinetic and crystallographic studies. European Journal of Medicinal Chemistry. 145. 649–660. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorraine M. Deck Breakdown of academic impact, for papers by Lucy A. Hunsaker Breakdown of academic impact, for papers by Vincent Kam Wai Wong Breakdown of academic impact, for papers by Rongsheng Tong Breakdown of academic impact, for papers by Alena Líšková Breakdown of academic impact, for papers by Dharmendra Kumar Yadav Breakdown of academic impact, for papers by Rosanna Filosa Breakdown of academic impact, for papers by Viney Lather Breakdown of academic impact, for papers by Maija Lahtela‐Kakkonen Breakdown of academic impact, for papers by Chenglong Li
Rankless by CCL
2026